Immobilization of antibacterial dihydropyrrol-2-ones on functional polymer supports to prevent bacterial infections in vivo

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 1138-1141

  Ho, Kitty Ka Kit ^a   Cole, Nerida ^a,b   Chen, Renxun ^a   Willcox, Mark D P ^a,b   Rice, Scott A ^a,c   Kumar, Naresh ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BRIEN HOLDEN VISION INSTITUTE   (Australia)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DIHYDROPYRROL 2 ONE DERIVATIVE; POLYACRYLAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; COVALENT BOND; DOSE RESPONSE; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

ACRYLIC RESINS; ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS; MALE; MICE; MICROSPHERES; POLYMERS; PROSTHESIS-RELATED INFECTIONS; PYRROLES; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84856075447     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05814-11     Document Type: Article

References (17)

1. Defoirdt T, Boon N, Bossier P. 2010. Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog. 6:e1000989.
2. Ford CW, Hamel JC, Stapert D, Yancey RJ. 1989. Establishment of an experimental model of a staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. Med. Microbiol. 28:259-266. (Pubitemid 19104482)
3. Hentzer M, Givskov M. 2003. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest. 112:1300-1307. (Pubitemid 38057681)
4. Ho KKK, et al. 2010. Characterisation and in vitro activities of surface attached dihydropyrrol-2-ones against gram-negative and gram-positive bacteria. Biofouling 26:913-921.
5. Hume EBH, et al. 2004. The control of staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials 25:5023-5030. (Pubitemid 38520831)
6. Hume EBH, et al. 2005. A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol. Cell Biol. 83:294-300. (Pubitemid 40799558)
7. Irwin P, et al. 2010. Antimicrobial activity of spherical silver nanoparticles prepared using a biocompatible macromolecular capping agent: evidence for induction of a greatly prolonged bacterial lag phase. J. Nanobiotechnology 8:34.
8. Kell DB, Kaprelyants AS, Weichart DH, Harwood CR, Barer MR. 1998. Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie Van Leeuwenhoek 73:169-187. (Pubitemid 28375465)
9. Kuehl R, et al. 2009. Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxs repression. Antimicrob. Agents Chemother. 53:4159-4166.
10. Kumar N, Iskander G. April 2008. Furanone compounds and lactam analogues thereof. WO patent 2,008,040,097.
11. Kumar N, Iskander G. August 2007. Novel lactams. WO patent 2,007,085,042.
12. Manefield M, et al. 1999. Evidence that halogenated furanones from delisea pulchra inhibit acylated homoserine lactone (ahl)-mediated gene expression by displacing the ahl signal from its receptor protein. Microbiology 145:283-291. (Pubitemid 29090083)
13. Neu HC. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
14. Oliver JD. 2005. The viable but nonculturable state in bacteria. J. Microbiol. 43:93-100. (Pubitemid 40431505)
15. Qazi S, et al. 2006.N-Acylhomoserine lactones antagonize virulence gene expression and quorum sensing in staphylococcus aureus. Infect. Immun. 74:910-919. (Pubitemid 43185524)
16. Rasmussen TB, et al. 2000. How delisea pulchra furanones affect quorum sensing and swarming motility in Serratia liquefaciens mg1. Microbiology 146:3237-3244. (Pubitemid 32042104)
17. Tenover FC. 2001. Development and spread of bacterial resistance to antimicrobial agents: an overview. Clin. Infect. Dis. 33:S108-S115. (Pubitemid 32835777)